查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1929520

人工智慧内视镜市场按类型、产品类型、组件、成像技术、应用和最终用户划分，全球预测（2026-2032年）

AI Endoscope Market by Type, Product Type, Component, Imaging Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，人工智慧内视镜市场价值将达到 10.5 亿美元，到 2026 年将成长至 11.3 亿美元，到 2032 年将达到 16.5 亿美元，年复合成长率为 6.59%。

关键市场统计数据
基准年 2025 10.5亿美元
预计年份：2026年 11.3亿美元
预测年份 2032 16.5亿美元
复合年增长率 (%) 6.59%

本文简要概述了光学创新、数位整合和临床重点如何融合，从而重新定义内视镜在现代医学中的效用和采购方式。

临床诊断影像领域正迈入一个新阶段，先进的光学技术、计算影像处理和协作工作流程正在融合，重塑临床医生观察和治疗体内结构的方式。内视镜已从独立的光学仪器发展成为整合平台，整合了高清感测器、照明系统、处理器以及日益复杂的软体层。随着医疗系统致力于改善治疗效果、缩短手术时间并控製成本，这些工具正在重新设计，以支持各个专科的微创治疗。

影像技术的进步、感染控制的需求以及供应链的韧性正在如何改变医疗机构中内视镜的设计、部署和采购方式？

内视镜市场正经历着一场变革性的转变，这场转变由多种相互作用的因素所驱动，正在改变产品设计、临床工作流程和商业策略。首先，对更清晰影像的需求正在加速高解析度感测器和三维成像技术的应用，从而实现更精准的诊断和治疗性介入。这种视觉清晰度，结合影像增强和即时分析等电脑辅助技术，正在提升临床医生的决策能力，并减少操作者之间的差异。

分析 2025 年关税变化如何重塑采购方式、定价策略和监管途径，从而推动製造商和医疗保健系统进行策略调整。

2025年关税对医疗设备业的采购趋势和供应链结构产生了显着影响，尤其对内视镜等复杂、资本密集产品的影响更为强烈。为此，製造商和医疗系统重新评估了其筹资策略，以控製成本风险并最大限度地减少业务中断。许多供应商加快了製造地多元化、投资区域组装能力或将零件采购转移到受影响关税区以外的地区等倡议，以保持价格竞争力和服务前置作业时间。

详细的細項分析揭示了设备形态、临床应用、使用者环境、组件生态系统和成像方式如何驱动差异化价值和购买行为。

细分市场分析揭示了产品形态、临床应用、最终用户、产品生命週期策略、组件架构和成像方式如何对设计选择和市场推广策略施加不同的影响。形态因素将市场细分为软式内视镜视镜和硬式内视镜，其中软式内视镜通常又可细分为可重复使用和一次性使用，这种二元性迫使供应商在可重复使用性和一次性产品的便利性之间取得平衡。关节镜、胃肠内视镜、妇科、腹腔镜和泌尿系统等应用领域具有显着不同的临床需求，这为针对特定应用的光学设计、人体工学和配件生态系统创造了机会。

临床基础设施、采购惯例和法规环境的区域差异如何决定全球采用路径和供应商价值提案

区域趋势对产品采纳、监管路径、报销框架和供应商策略均有显着影响。在美洲，成熟的医院系统和门诊手术中心优先考虑与电子健康记录的整合、高通量再处理流程以及临床效益的证据。因此，供应商通常强调服务协议、培训计划和总成本考量。放眼东方，欧洲、中东和非洲地区呈现出多元化的格局，欧洲部分地区的监管趋于统一，而其他次区域的采购模式和基础架构层存在差异。在这些地区，支付方和医疗机构会综合考虑临床疗效、国家采购法规以及当地的生产和供应情况来评估医疗器材。

检验内视镜市场的竞争、伙伴关係主导的创新以及服务导向商业模式如何重新定义供应商定位和客户期望。

内视镜市场的竞争格局呈现出复杂多样的特点，既有老牌厂商，也有新兴的专业公司，还有试图利用数位化和一次性使用趋势来抢占市场份额的新参与企业。老牌厂商持续投资于光学性能、耐用性和服务网络的改进，专注于与大型医疗系统建立长期合作关係，并提供复杂的服务。同时，小规模、更灵活的厂商则利用一次性技术、特定应用设备和针对性的临床伙伴关係，加速在特定细分市场的推广应用。

在不断变化的医疗保健环境中，製造商和供应商需要采取具体的策略行动来延长产品寿命、增强供应韧性、加速临床应用并提高商业性柔软性。

产业领导者应优先采取一系列切实可行的措施，以提升临床价值、降低营运风险并巩固市场地位。首先，应有选择地投资于模组化、互通性的架构，使摄影机、处理器、显示器和配件等组件能够独立昇级。这不仅能降低产品过时的风险，还能让产品蓝图与医院的IT生命週期一致。其次，应针对可重复使用和一次性产品製定清晰、基于实证的价值提案，透明地阐述感染预防措施、再处理负担和环境影响，从而帮助采购方做出明智的权衡决策。

采用严谨的混合方法研究方法，结合临床医师访谈、技术检验和多学科检验方法，得出可操作且检验的市场洞察。

本研究综合运用混合方法，结合关键相关人员访谈、专家小组咨询和严谨的二手资料分析，以确保研究结果的平衡性和观点。主要工作包括对各外科专科的临床医生、医院和门诊手术中心的采购主管以及医疗设备製造商和分销商的高级管理人员进行结构化访谈。此外，还与临床工程师和再处理专家举行了技术审查会议，检验营运影响和生命週期的考量，从而补充了这些定性研究结果。

本文简要概述了技术、营运和政策力量如何汇聚，从而推动兼具临床疗效和具有韧性、以服务为导向的经营模式的解决方案的出现。

总之，内视镜领域正处于策略转折点，光学创新、数位化、感染预防和供应链适应性将共同决定哪些解决方案将在医疗保健领域占据主导地位。可重复使用和一次性使用模式之间的相互作用仍将是核心主题，并受到临床证据、环境因素和组织优先事项的影响。同时，影像技术的进步，特别是3D视觉化和计算支援的进步，有望提升临床能力，但需要明确证明其能改善临床结果，才能证明其高价应用的合理性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 人工智慧内视镜市场（按类型划分）

  • 灵活的
    • 可重复使用的
    • 一次性
  • 硬度

第九章 人工智慧内视镜市场（依产品类型划分）

  • 可重复使用的
  • 一次性

第十章 人工智慧内视镜市场（按组件划分）

  • 配件
  • 相机
  • 供气设备
  • 光源
  • 监视器
  • 处理器

第十一章 人工智慧内视镜市场（依影像技术划分）

  • 二维成像
  • 三维成像

第十二章 人工智慧内视镜市场（按应用划分）

  • 关节镜
  • 胃肠内视镜检查
  • 妇科
  • 腹腔镜
  • 泌尿系统

第十三章 人工智慧内视镜市场（按最终用户划分）

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院

第十四章 人工智慧内视镜市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 人工智慧内视镜市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国人工智慧内视镜市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国人工智慧内视镜市场

第十八章：中国的人工智慧内视镜市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arthrex Inc.
  • Boston Scientific Corporation
  • CONMED Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hoya Corporation
  • Intuitive Surgical Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Philips Healthcare
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-0A38069517F0

The AI Endoscope Market was valued at USD 1.05 billion in 2025 and is projected to grow to USD 1.13 billion in 2026, with a CAGR of 6.59%, reaching USD 1.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.05 billion
Estimated Year [2026] USD 1.13 billion
Forecast Year [2032] USD 1.65 billion
CAGR (%) 6.59%

A concise overview of how optical innovation, digital integration, and clinical priorities are converging to redefine endoscope utility and procurement in modern care

The clinical imaging landscape is moving into a new phase where advanced optics, computational imaging, and connected workflows converge to reshape how clinicians visualize and treat internal anatomy. Endoscopes have evolved from standalone optical devices into integrated platforms that combine high-fidelity sensors, lighting systems, processors, and increasingly intelligent software layers. As healthcare systems seek to improve outcomes, reduce procedural time, and manage costs, these tools are being redesigned to support minimally invasive care across a broad spectrum of specialties.

Technological advances are enabling richer intraoperative visualization, and at the same time manufacturers are reimagining device lifecycles, service models, and supply chains. Adoption patterns vary by clinical application, setting, and economic context, yet a common theme is the drive toward more efficient, safer, and data-rich procedures. Clinicians and procurement teams are balancing clinical benefits with device ergonomics, reprocessing burden, and total cost of ownership. In this context, a strategic view of endoscope innovation is essential for stakeholders who must align patient safety, regulatory compliance, and commercial viability.

Consequently, stakeholders must consider not only optical and mechanical performance but also digital interoperability, disposable versus reusable trade-offs, and the implications of emerging reimbursement and procurement frameworks. These factors collectively influence how technologies will be adopted and which business models will succeed in the near to mid term.

How imaging advancements, infection control imperatives, and supply chain resilience are collectively reshaping endoscope design, adoption, and procurement across care settings

The endoscope market is undergoing transformative shifts driven by several intersecting forces that are altering product design, clinical workflows, and commercial strategies. First, the push for enhanced visualization has accelerated adoption of higher-resolution sensors and three-dimensional imaging capabilities, enabling more precise diagnostics and therapeutic interventions. This visual clarity is increasingly paired with computational assistance, such as image enhancement and real-time analytics, which augment clinician decision-making and reduce variability across operators.

Second, infection prevention concerns and operational efficiency are reshaping demand toward single-use options in many settings, while hybrid approaches combining reusable cores with disposable components are gaining traction. At the same time, tighter hospital budgets and emphasis on procedure throughput are steering adoption toward solutions that lower reprocessing costs and reduce turnaround times. Third, the digitization of operating rooms and integration with hospital information systems require endoscopes and their processors to communicate seamlessly with broader clinical IT environments, influencing procurement criteria and vendor selection.

Finally, global supply chain resilience and regional manufacturing strategies are becoming central to vendor value propositions. Providers increasingly evaluate suppliers not only on device performance but also on controllable logistics, spare parts availability, and service responsiveness. Taken together, these shifts create opportunities for innovators who can deliver clinically differentiated imaging, pragmatic infection-control solutions, and robust support models that align with institutional priorities.

An analysis of how tariff changes in 2025 reshaped sourcing, pricing tactics, and regulatory pathways, prompting strategic adjustments across manufacturers and health systems

Tariff policies adopted in 2025 have had a tangible influence on procurement dynamics and supply chain configurations across the medical device sector, with particular implications for complex capital-intensive products such as endoscopes. In response, manufacturers and health systems have revisited sourcing strategies to manage cost exposure and minimize operational disruption. Many suppliers accelerated efforts to diversify manufacturing footprints, invest in regional assembly capabilities, or shift component sourcing to jurisdictions outside of affected tariff zones to preserve competitive pricing and service lead times.

Concurrently, hospital procurement teams have intensified scrutiny of landed costs, total cost of ownership, and contractual protections against future tariff volatility. Where tariffs increased landed costs, some institutions leaned toward contractual hedges and multi-year agreements to stabilize procurement budgets. Others experimented with alternative product mixes, including greater use of single-use endoscopes where logistical simplicity and predictable per-case costing offset higher per-unit prices.

Moreover, regulatory and compliance considerations shaped responses, as repatriation or regionalization of production required new validations, quality audits, and documentation to meet local market requirements. These incremental compliance burdens extended timelines for product introductions in certain jurisdictions, prompting manufacturers to prioritize product lines with the clearest clinical and economic value. Overall, the cumulative tariff-driven effects emphasized the strategic importance of manufacturing agility, robust supplier networks, and clear communication between commercial, regulatory, and supply chain teams.

Detailed segmentation insights demonstrating how device form, clinical application, user setting, component ecosystems, and imaging modality drive differentiated value and purchasing behavior

Segmentation analysis reveals how product form, clinical application, end user, product lifecycle strategy, component architecture, and imaging modality each exert distinct pressures on design choices and go-to-market approaches. When considering type, the market differentiates between flexible and rigid endoscopes, with flexible devices often subdivided into reusable and single-use forms; this duality forces vendors to balance reprocessing capabilities against disposability-driven convenience. Across applications such as arthroscopy, gastrointestinal endoscopy, gynecology, laparoscopy, and urology, clinical requirements diverge significantly, creating opportunities for application-specific optics, ergonomics, and accessory ecosystems.

End users show heterogeneous priorities: ambulatory surgical centers and clinics typically emphasize throughput and per-procedure cost predictability, diagnostic centers prioritize image fidelity and reporting workflows, while hospitals demand robustness, serviceability, and integration with complex IT systems. Product type discussions return repeatedly to the reusable versus single-use debate, where life-cycle costs, infection prevention protocols, and environmental considerations shape procurement decisions. Component segmentation underscores the importance of modular architectures; accessories, cameras, insufflators, light sources, monitors, and processors represent distinct value pools that can be bundled or sold independently depending on customer needs and service strategies.

Finally, imaging technology choices between 2D and 3D imaging create different clinical narratives: 2D systems prioritize proven compatibility and cost-effectiveness, while 3D imaging targets surgical specialties that benefit from depth perception and enhanced spatial orientation. Taken together, these segmentation lenses provide a nuanced map for product development, clinical validation, and targeted commercial messaging.

How regional variations in clinical infrastructure, procurement practices, and regulatory environments are defining adoption pathways and supplier value propositions worldwide

Regional dynamics materially influence product adoption, regulatory pathways, reimbursement frameworks, and supplier strategies. In the Americas, established hospital systems and ambulatory surgical centers prioritize integration with electronic health records, high-throughput reprocessing workflows, and evidence demonstrating clinical benefit; consequently, suppliers often emphasize service contracts, training programs, and total cost considerations. Transitioning eastward, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization in parts of Europe contrasts with disparate procurement models and infrastructure levels in other subregions. Here, payers and institutions evaluate devices through a mix of clinical efficacy, national procurement rules, and local manufacturing or supply considerations.

Across Asia-Pacific, rapid hospital expansion, rising procedural volumes, and varying regulatory maturity create both opportunities and complexities for vendors. Some markets within the region are highly cost-sensitive and favor pragmatic single-use options or lower-cost 2D imaging systems, while others are investing aggressively in high-end visualization and 3D platforms to support advanced surgical programs. Supply chain geography also matters; proximity to manufacturing hubs can shorten lead times and influence competitive positioning. In summary, regional strategies must align product portfolios, pricing models, and regulatory roadmaps with the distinct clinical, economic, and infrastructural realities of each territory.

Examining competitive dynamics, partnership-led innovation, and service-oriented commercial models that are redefining supplier positioning and customer expectations in the endoscope market

Competitive dynamics in the endoscope landscape are characterized by a mix of legacy incumbents, emerging specialists, and new entrants leveraging digital and disposability trends to gain share. Established manufacturers continue to invest in incremental improvements across optics, durability, and service networks, focusing on long-standing relationships with large health systems and complex service offerings. At the same time, smaller and more agile players are capitalizing on single-use technologies, application-specific devices, and targeted clinical partnerships to accelerate adoption in focused niches.

Partnerships between imaging specialists and software or analytics firms have become common, as vendors seek to deliver clinically meaningful workflows rather than isolated hardware. Service-led business models, including subscription-based access to imaging platforms and outcome-linked contracting, are gaining attention as purchasers look to align costs with utilization and clinical performance. Additionally, aftermarket components and accessory ecosystems represent high-margin areas where suppliers can differentiate through compatibility, ease of use, and bundled training.

Finally, strategic M&A activity and distribution alliances continue to reshape the competitive map. Companies that combine manufacturing scale with software prowess and regional service depth are increasingly positioned to win institutional contracts. For decision-makers, the critical lens should be on supplier reliability, clarity of upgrade and service paths, and demonstrable clinical outcomes rather than on isolated product specifications.

Concrete strategic actions for manufacturers and providers to improve product longevity, supply resilience, clinical adoption, and commercial flexibility in evolving care settings

Industry leaders should prioritize a set of practical, actionable moves to capture clinical value, mitigate operational risk, and strengthen market position. First, invest selectively in modular and interoperable architectures that allow components such as cameras, processors, monitors, and accessories to be upgraded independently; this reduces obsolescence risk and aligns product roadmaps with hospital IT lifecycles. Second, develop clear, evidence-based value propositions for reusable versus single-use offerings that transparently account for infection prevention, reprocessing burdens, and environmental impacts so that buyers can make informed trade-offs.

Third, build resilient supply chains by diversifying manufacturing and assembly locations while strengthening supplier relationships for critical subcomponents to minimize tariff and logistics exposure. Fourth, emphasize post-sale support models that include training, preventive maintenance, and rapid parts replacement to underpin long-term contracts with major health systems. Fifth, pursue targeted clinical collaborations to validate advanced imaging features such as 3D visualization and AI-assisted analytics in high-impact procedures; real-world evidence will accelerate adoption and justify premium positioning.

Finally, adopt flexible commercial models, including leasing, outcome-based agreements, and bundled service contracts that align with purchaser preferences across ambulatory centers, clinics, diagnostic centers, and hospitals. Executing on these recommendations will require cross-functional alignment among product, regulatory, and commercial teams but will materially improve competitiveness and relevance in a rapidly evolving market.

A rigorous mixed-methods research approach integrating clinician interviews, technical validations, and multi-source triangulation to produce practical and verifiable market insights

This research synthesizes insights from a mixed-methods approach combining primary stakeholder interviews, expert panel consultations, and rigorous secondary-source analysis to ensure a balanced and actionable perspective. Primary engagements included structured interviews with clinicians across surgical specialties, procurement leaders from hospitals and ambulatory surgical centers, and senior executives from device manufacturers and distributors. These qualitative inputs were complemented by technical review sessions with clinical engineers and reprocessing specialists to validate operational implications and lifecycle considerations.

Secondary analysis encompassed regulatory filings, peer-reviewed clinical literature on imaging and infection control, device technology white papers, and public filings that illuminate company strategies and product claims. Data were triangulated across sources to identify consistent patterns and to reconcile divergent viewpoints. Special attention was given to regional regulatory frameworks and supply chain constraints to ensure that geographic insights reflect real-world constraints and opportunities.

Throughout the process, methodological safeguards were applied to minimize bias, including cross-validation of interview findings, anonymization of sensitive inputs to encourage candor, and iterative review cycles with clinical experts. Limitations are acknowledged: evolving tariff and regulatory landscapes may shift operational details, and local procurement idiosyncrasies can affect transferability. Nevertheless, the methodology supports robust, practical conclusions that can inform strategic planning and vendor selection.

A concise summation of how technological, operational, and policy forces converge to favor solutions that pair clinical impact with resilient, service-oriented business models

In conclusion, the endoscope sector is at a strategic inflection point where optical innovation, digitization, infection prevention, and supply chain adaptability collectively determine which solutions gain traction across care settings. The interplay between reusable and single-use paradigms will remain a central theme, shaped by clinical evidence, environmental considerations, and institutional priorities. Meanwhile, advancements in imaging technology, especially 3D visualization and computational assistance, promise to augment clinical capabilities but will require clear demonstration of outcome improvements to justify premium adoption.

Regional nuances and policy shifts-such as tariff-driven supply chain adjustments-underscore the importance of manufacturing flexibility and transparent total cost discussions between vendors and purchasers. Suppliers that can pair clinical differentiation with robust service models and flexible commercial arrangements will be best positioned to win long-term relationships with hospitals, ambulatory surgical centers, and diagnostic facilities. For clinical leaders, procurement teams, and investors, the critical focus should be on solutions that deliver measurable clinical benefits, integrate effectively into digital workflows, and present defensible value propositions when evaluated against operational realities.

Ultimately, successful market participants will be those that combine technical excellence with pragmatic business models, clear evidence generation, and resilient operational infrastructures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI Endoscope Market, by Type

  • 8.1. Flexible
    • 8.1.1. Reusable
    • 8.1.2. Single Use
  • 8.2. Rigid

9. AI Endoscope Market, by Product Type

  • 9.1. Reusable
  • 9.2. Single Use

10. AI Endoscope Market, by Component

  • 10.1. Accessories
  • 10.2. Camera
  • 10.3. Insufflator
  • 10.4. Light Source
  • 10.5. Monitor
  • 10.6. Processor

11. AI Endoscope Market, by Imaging Technology

  • 11.1. 2D Imaging
  • 11.2. 3D Imaging

12. AI Endoscope Market, by Application

  • 12.1. Arthroscopy
  • 12.2. Gastrointestinal Endoscopy
  • 12.3. Gynecology
  • 12.4. Laparoscopy
  • 12.5. Urology

13. AI Endoscope Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Diagnostic Centers
  • 13.4. Hospitals

14. AI Endoscope Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. AI Endoscope Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. AI Endoscope Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States AI Endoscope Market

18. China AI Endoscope Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Arthrex Inc.
  • 19.6. Boston Scientific Corporation
  • 19.7. CONMED Corporation
  • 19.8. Fujifilm Holdings Corporation
  • 19.9. GE HealthCare Technologies Inc.
  • 19.10. Hoya Corporation
  • 19.11. Intuitive Surgical Inc.
  • 19.12. Johnson & Johnson
  • 19.13. Karl Storz SE & Co. KG
  • 19.14. Medtronic plc
  • 19.15. Olympus Corporation
  • 19.16. Philips Healthcare
  • 19.17. Richard Wolf GmbH
  • 19.18. Siemens Healthineers AG
  • 19.19. Smith & Nephew plc
  • 19.20. Stryker Corporation
  • 19.21. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI ENDOSCOPE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI ENDOSCOPE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI ENDOSCOPE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI ENDOSCOPE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI ENDOSCOPE MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI ENDOSCOPE MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI ENDOSCOPE MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI ENDOSCOPE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CAMERA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CAMERA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CAMERA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI ENDOSCOPE MARKET SIZE, BY INSUFFLATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI ENDOSCOPE MARKET SIZE, BY INSUFFLATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI ENDOSCOPE MARKET SIZE, BY INSUFFLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LIGHT SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LIGHT SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LIGHT SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI ENDOSCOPE MARKET SIZE, BY MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI ENDOSCOPE MARKET SIZE, BY MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI ENDOSCOPE MARKET SIZE, BY MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PROCESSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI ENDOSCOPE MARKET SIZE, BY PROCESSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI ENDOSCOPE MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI ENDOSCOPE MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI ENDOSCOPE MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI ENDOSCOPE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI ENDOSCOPE MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI ENDOSCOPE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI ENDOSCOPE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI ENDOSCOPE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI ENDOSCOPE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI ENDOSCOPE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI ENDOSCOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI ENDOSCOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AI ENDOSCOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AI ENDOSCOPE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AI ENDOSCOPE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AI ENDOSCOPE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AI ENDOSCOPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS AI ENDOSCOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AI ENDOSCOPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. GCC AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 181. G7 AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. NATO AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL AI ENDOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA AI ENDOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA AI ENDOSCOPE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA AI ENDOSCOPE MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA AI ENDOSCOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA AI ENDOSCOPE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA AI ENDOSCOPE MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA AI ENDOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA AI ENDOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)